GENE ONLINE|News &
Opinion
Blog

2025-09-03|

India’s Pharmaceutical and Healthcare Sectors Raise $47 Million Across Seven Deals in August 2025

by Mark Chiang
Share To

India’s pharmaceutical and healthcare sectors experienced a significant drop in funding during August 2025, with total capital raised reaching $47 million across seven deals. This marks a notable decline compared to previous months, as reported by Tracxn, a global data intelligence platform tracking investments and startups.

The figures highlight reduced investor activity in these industries for the month. The seven deals collectively represent a sharp contraction in funding levels, suggesting potential shifts in market dynamics or investment priorities within India’s healthcare and pharmaceutical landscape. Further details on the nature of these deals or contributing factors to the downturn were not disclosed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: September 3, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top